01
Build the complete record
Every report, scan, and note goes into one private workspace, so nothing has to be found twice.
For complex cancer cases
We help you Find every option. Reach the treatment. Know what comes next.
When standard of care is not enough, LightWay takes on the hard casework. We read every report, dig into the tumor's biology, and help you and your oncologist pursue the routes with real evidence behind them.
Human review. Evidence tied to the record. Doctor-led decisions.
Our process
We stay on the case from first records to treatment.
Patients and families should not have to become cancer researchers on top of everything else. We do the reading, the comparing, and the chasing — and we stay with the case until treatment is moving.
Treatment lanes preview
02
Analyze the tumor biology
We work through what is driving this tumor — and what that opens or closes for treatment.
03
Develop and rank the options
Every route gets compared on the same three things: evidence, timing, and what it asks of the patient.
04
Prepare and pursue access
We handle the outreach and the paperwork that move a chosen route toward an actual start.
05
Keep the case current
New results change the plan, not just the file.
Inside the work
Your facts stay separate from everyone else's evidence.
A result from your own biopsy and a claim from a published paper are different kinds of truth. The workspace keeps them apart, so you always know which one you are reading.
Depth matters, but it has to stay readable.
A hard case runs to hundreds of pages. We keep every detail next to the conclusion it supports, so you can check our reasoning without having to read like a researcher.
Own record
What is true for this patient
Diagnosis, current disease state, prior treatment, response, available tissue, and test results.
Biology
What the tumor may make possible
Targets, mutations, expression, immune signals, and checks that could open or close a route.
External evidence
What has helped other patients
Published studies, approvals, trial results, and case reports are separated from the patient's own facts.
Access work
What has to happen next
Trial outreach, physician questions, manufacturer contacts, regulatory routes, and practical timing.
What we do
We look at every treatment option that may fit your cancer.
The search starts with standard care and does not stop there. Every route gets a reason, a source, and a next step — all tied to your own record.
Standard of care
Put the current options in context
How well the approved treatments fit this particular case — and what they leave uncovered.
Trials
Find trials that fit the case
Which studies genuinely fit this biology and this timing — and how to approach them.
Targeted and off-label
Test drug ideas against the evidence
We check each drug idea against the evidence before it goes anywhere near a decision.
Vaccine
Evaluate personalized vaccine paths
When the biology supports it, we map the peptide and mRNA routes — what each needs, and how long it takes.
International
Look beyond the patient's country
Treatments and trials abroad, weighed honestly against what the travel would demand.
Hard-to-reach options
Build access routes for hard-to-reach options
For drugs with no obvious route, we assemble the evidence a manufacturer or regulator would need to say yes.
Getting treatment access
Finding a treatment option is only the first step.
Naming the right treatment is not the same as getting it. Much of our work is the unglamorous part — eligibility, outreach, and giving each gatekeeper the evidence they ask for.
Care team
A decision-ready case packet
Current status, prioritized options, supporting evidence, unresolved questions, and the action each route requires.
Trial sites
Eligibility and outreach
Which studies are worth contacting, what they will ask for, and what could rule the patient in or out.
Drug companies
Manufacturer treatment requests
For drugs outside the usual route, we help assemble the medical rationale and supporting evidence.
Regulatory
Special approval pathways
Where it fits, we prepare the evidence a physician needs to request expanded access or a single-patient IND.
Treatment and access routes
One analysis can lead to several ways to pursue treatment.
First, understand the case. Then the work branches — each route asks for different preparation, and several usually run at once.
From record review to treatment routes
Open the full view
Start
The full cancer record
Reports, scans, pathology, sequencing, prior treatments, response, and open questions.
Review
Tumor biology and treatment context
What is happening now, what is targetable, what has already been tried, and what evidence is still needed.
Standard of care
Compare the current options
Put approved treatments in context with the tumor biology, prior therapy, and current disease state.
Trial
Find a study that fits
Match diagnosis, markers, prior therapy, timing, and location.
Vaccine
Build a personalized route
Evaluate peptide or mRNA options when the tumor biology supports it.
Targeted or off-label
Build the drug rationale
Connect the tumor finding to the drug, evidence, tissue checks, and clinical context.
International
Review options outside the country
Identify relevant treatments or trials and what travel, timing, and records would be required.
Special approval
Prepare manufacturer or regulatory requests
Prepare the evidence a physician, manufacturer, or regulator may need for an expanded or single-patient pathway.
Output
A prioritized plan with access work underway
The patient and oncologist can see what is possible now, what is being prepared, and what still needs to happen.
The exact route depends on the patient, the tumor, prior treatment, available tissue, location, timing, and physician review.
LightWay Hub
Everything about the case stays in one place.
Cancer care scatters across portals, inboxes, and printouts. The Hub keeps the whole case together and current — for you, your family, and your care team.
LightWay Hub preview
Current status
What is true now and what needs attention
Disease state, recent changes, overdue follow-ups, and the next action.
Evidence
The reports and sources behind each finding
Every claim links back to the report it came from.
Tumor biology
Sequencing, mutations, expression, and immune markers
What makes this tumor specific, what may be targetable, and what needs confirmation.
Treatment choices
Standard of care, trials, drugs, vaccines, and access routes
What is available now, what requires an access request, and what needs more evidence.
Preparation
What should be ready before it is needed
Biopsies, stains, trial packets, and the questions to ask at the next appointment.
Tracking
What could change the plan later
Surveillance timing, milestones, trial changes, review dates, and open questions.
For the family around the patient
LightWay holds the case with you.
Someone in every family becomes the record keeper, the trial researcher, the second-opinion coordinator. LightWay takes the heavy part of that job and keeps you in the loop as things change.
See where things stand
Current status, recent changes, overdue follow-ups, and the next action are kept in one view.
Understand what changed
New scans, labs, pathology, or sequencing are compared with the prior record and the existing plan.
Know what is being prepared
Treatment options, tissue checks, trial work, treatment request packets, and backup paths remain visible before they are needed.
Move treatment access forward
We gather the evidence and the contacts, then help coordinate the route with the care team.
Important boundary: LightWay does not diagnose, prescribe, or replace your medical team. We organize, analyze, and prepare — treatment decisions stay with the patient and their doctors.